Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
third rock ventures
acetylon pharmaceuticals
ally bridge group
ambys medicines
anti aging
artificial intelligence
balderton capital
big data
big data analytics
big pharma
blackrock
boston
business
c4 therapeutics
calico
calico news
cancer
casdin capital
cell therapy
clinical trials
cloud
constellation pharmaceuticals
deals
diabetic nephropathy
dna sequencing
drugs
entrepreneur
europe
eventide asset management
focal segmental glomerulosclerosis
fundings & exits
gene therapy
genentech
goldfinch bio
What
biotech
4
×
diseases
4
×
new
startup
big
cancer
develop
medicines
aging
aiming
algorithms
alzheimer’s
ambys
analysis
analytics
anti
balderton
based
better
bio
bring
built
cagey
calico
certainly
clinicians
company
control
data
deadly
deal
debuted
diagnoses
diagnostic
diagnostics
drug
drugs
employing
encompasses
enhance
Language
unset
Current search:
biotech
×
biotech
×
diseases
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@techcrunch.com
6 years ago
Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics
@venturebeat.com
7 years ago
Google’s Calico partners with new biotech firm to develop anti-aging and cancer drugs